Search research articles
Contact Us
Filters
Showing results (1011-1020 of 1,040) with videos related to
Page
of 104
Sort By:
Nature Genetics
|
March 30, 2021
Ultraconserved enhancer function does not require perfect sequence conservation
Valentina Snetkova, Athena R Ypsilanti, Jennifer A Akiyama, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Uncovering the Regional and Cell Specific Bioactivity of Injectable Extracellular Matrix Biomaterials in Myocardial Infarction through Spatial and Single Nucleus Transcriptomics
Joshua M Mesfin, Van K Ninh, Miranda D Diaz, et al.
Remote Sensing
|
February 23, 2023
Integrating Inland and Coastal Water Quality Data for Actionable Knowledge
Ghada Y H El Serafy, Blake A Schaeffer, Merrie-Beth Neely, et al.
The New England Journal of Medicine
|
February 25, 2021
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Ivan O Rosas, Norbert Bräu, Michael Waters, et al.
Human Mutation
|
September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects
Rajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
March 19, 2021
Oral lesions containing amyloid-like material
Carla Isabelly Rodrigues-Fernandes, Cinthia Bardález López de Cáceres, Maria Sissa Pereira Sant'Ana, et al.
Physical Review Letters
|
May 7, 2003
21Na(p,gamma)22Mg reaction and oxygen-neon novae
S Bishop, R E Azuma, L Buchmann, et al.
Blood
|
March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.
Nature Communications
|
August 7, 2025
Uncovering hidden enhancers through unbiased in vivo testing
Brandon J Mannion, Stella Tran, Ingrid Plajzer-Frick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
Caron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Page
of 104
Search research articles
Search
Showing results (1011-1020 of 1,040) with videos related to
Sort By:
Page
of 104
Nature Genetics
|
March 30, 2021
Ultraconserved enhancer function does not require perfect sequence conservation
Valentina Snetkova, Athena R Ypsilanti, Jennifer A Akiyama, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Uncovering the Regional and Cell Specific Bioactivity of Injectable Extracellular Matrix Biomaterials in Myocardial Infarction through Spatial and Single Nucleus Transcriptomics
Joshua M Mesfin, Van K Ninh, Miranda D Diaz, et al.
Remote Sensing
|
February 23, 2023
Integrating Inland and Coastal Water Quality Data for Actionable Knowledge
Ghada Y H El Serafy, Blake A Schaeffer, Merrie-Beth Neely, et al.
The New England Journal of Medicine
|
February 25, 2021
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Ivan O Rosas, Norbert Bräu, Michael Waters, et al.
Human Mutation
|
September 22, 2015
Pulmonary Arterial Hypertension: A Current Perspective on Established and Emerging Molecular Genetic Defects
Rajiv D Machado, Laura Southgate, Christina A Eichstaedt, et al.
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
|
March 19, 2021
Oral lesions containing amyloid-like material
Carla Isabelly Rodrigues-Fernandes, Cinthia Bardález López de Cáceres, Maria Sissa Pereira Sant'Ana, et al.
Physical Review Letters
|
May 7, 2003
21Na(p,gamma)22Mg reaction and oxygen-neon novae
S Bishop, R E Azuma, L Buchmann, et al.
Blood
|
March 3, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma
Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault, et al.
Nature Communications
|
August 7, 2025
Uncovering hidden enhancers through unbiased in vivo testing
Brandon J Mannion, Stella Tran, Ingrid Plajzer-Frick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 16, 2020
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity
Caron A Jacobson, Bradley D Hunter, Robert Redd, et al.
Page
of 104